Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

BACKGROUND: Ultra-hypofractionated image-guided stereotactic body radiotherapy (SBRT) is increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance imaging-guided radiotherapy (MRgRT) facilitates improved visualization, real-time tracking of targets and/or organs-at-...

Descripción completa

Detalles Bibliográficos
Autores principales: Marciscano, Ariel E., Wolfe, Sydney, Zhou, Xi Kathy, Barbieri, Christopher E., Formenti, Silvia C., Hu, Jim C., Molina, Ana M., Nanus, David M., Nauseef, Jones T., Scherr, Douglas S., Sternberg, Cora N., Tagawa, Scott T., Nagar, Himanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463903/
https://www.ncbi.nlm.nih.gov/pubmed/37608258
http://dx.doi.org/10.1186/s12885-023-11278-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463903/
https://www.ncbi.nlm.nih.gov/pubmed/37608258
http://dx.doi.org/10.1186/s12885-023-11278-3

Ejemplares similares